Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pauschinger

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Circulation|February 20, 2003
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanismHenry Fechner, Michel Noutsias, Carsten Tschoepe, et al.
Basic Research in Cardiology|March 19, 2008
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathySophie Van Linthout, Ute Seeland, Alexander Riad, et al.
The American Journal of Cardiology|October 21, 2016
Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry]Harm Wienbergen, Otmar Pfister, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 14, 2018
Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up studyHarm Wienbergen, Otmar Pfister, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 26, 2019
Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fractionClemens Jilek, Thorsten Lewalter, Matthias Pauschinger, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.
European Journal of Pharmacology|November 23, 2006
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditisJun Li, Sebastian Leschka, Susanne Rutschow, et al.
ESC Heart Failure|July 15, 2020
Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditisCarsten Tschöpe, Sophie Van Linthout, Sebastian Jäger, et al.
JACC. Heart Failure|July 13, 2025
Cardiac Magnetic Resonance Imaging vs Coronary Angiography as Primary Strategy in Newly Diagnosed Heart FailureGülmisal Güder, Theresa Reiter, Wolfgang R Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in miceAlexander Riad, Sebastian Jäger, Meike Sobirey, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Circulation|February 20, 2003
Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanismHenry Fechner, Michel Noutsias, Carsten Tschoepe, et al.
Basic Research in Cardiology|March 19, 2008
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathySophie Van Linthout, Ute Seeland, Alexander Riad, et al.
The American Journal of Cardiology|October 21, 2016
Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry]Harm Wienbergen, Otmar Pfister, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 14, 2018
Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up studyHarm Wienbergen, Otmar Pfister, Matthias Hochadel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 26, 2019
Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fractionClemens Jilek, Thorsten Lewalter, Matthias Pauschinger, et al.
Journal for Immunotherapy of Cancer|August 18, 2016
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapyLucie Heinzerling, Patrick A Ott, F Stephen Hodi, et al.
European Journal of Pharmacology|November 23, 2006
Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditisJun Li, Sebastian Leschka, Susanne Rutschow, et al.
ESC Heart Failure|July 15, 2020
Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditisCarsten Tschöpe, Sophie Van Linthout, Sebastian Jäger, et al.
JACC. Heart Failure|July 13, 2025
Cardiac Magnetic Resonance Imaging vs Coronary Angiography as Primary Strategy in Newly Diagnosed Heart FailureGülmisal Güder, Theresa Reiter, Wolfgang R Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in miceAlexander Riad, Sebastian Jäger, Meike Sobirey, et al.
Pageof 12